Canine Mediation in Psychomotor Therapy for Adults with Epilepsy
Official title: Impact of Canine Mediation Practice in Psychomotor Therapy on Improving the Quality of Life in Adult Epileptic Patients.
Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT06898749 · Data updated 2026-11-12
This study tests whether adding dog-assisted mediation to psychomotor therapy can improve quality of life for adults with pharmacoresistant epilepsy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild Research network |
| Locations | 2 sites (Saint-Étienne-de-Saint-Geoirs and 1 other locations) |
| Status | Recruiting |
| Started | September 14, 2026 |
| Main results expected | March 2030 |
| Study ends | March 2030 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT06898749 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18+ with pharmacoresistant epilepsy who need psychomotor therapy and have no dog phobia, able to consent, and able to attend sessions for at least 3 months at participating sites.
✕Probably not a fit
Individuals who are fearful of dogs, have legal protections restricting participation, or cannot complete the therapy schedule may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study explores whether incorporating canine mediation into standard psychomotor therapy affects quality of life in adults with epilepsy who do not respond well to medications. Participants will receive psychomotor therapy with a canine mediation component, alongside routine care, to observe potential changes in quality of life, anxiety, and possibly seizure frequency. The study targets adults 18 and older who require psychomotor therapy and meet the epilepsy criteria set by the International League Against Epilepsy. Exclusion criteria include dog phobia and certain legal protections that restrict participation. The investigation will be conducted at facilities in Saint-Étienne-de-Saint-Geoirs and Tain-l’Hermitage, under a framework of informed consent and image rights consent where applicable.
Why it matters
Potential benefit: If successful, participants may experience better quality of life and emotional well-being, with potential secondary effects on anxiety and seizure management.
How similar studies have gone: There is limited or no prior evidence in epilepsy for canine-assisted mediation in psychomotor therapy, making this a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Person aged ≥ 18 years * Presenting pharmacoresistant epilepsy according to the criteria of the International League Against Epilepsy * Requiring psychomotor therapy sessions for one of the following indications: Difficult emotional and relational management And/or global motor difficulties And/or body schema organization disorder And/or temporo-spatial disorder * Explicit consent or no opposition to participation in the study by the patient and/or their legal representative or guardian * Image rights consented by the patient and their legal representative or guardian, if applicable * Hospitalization or residence at the Teppe Institute or at the FAM (Foyer d'Accueil Médicalisé) des 4 Jardins planned for at least 3 months * Affiliated with or a beneficiary of a social security scheme Exclusion Criteria: * Fear or phobia of dogs * Epileptic person benefiting from a legal protection measure other than guardianship or curatorship * Person with insufficient cognitive abilities to respond to the questionnaires * Pregnant or breastfeeding woman
Where it's running
-
Institut La Teppe
Tain-l'Hermitage, France Recruiting -
Fondation Partage et Vie - FAM Les Quatre Jardins
Saint-Étienne-de-Saint-Geoirs, France Not yet recruiting
Study contacts
- Study coordinator: Amelie Yavchitz
- Email: ayavchitz@for.paris
- Phone: +33148036454
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Advanced 7T fMRI for brain function in epilepsy and brain injuries
This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.